AE Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,892
Closed -$212K 2202
2025
Q1
$212K Buy
+2,892
New +$239K ﹤0.01% 1256
2022
Q2
Sell
-2,998
Closed -$221K 1766
2022
Q1
$221K Buy
+2,998
New +$208K ﹤0.01% 1550
2021
Q4
Sell
-2,726
Closed -$209K 1725
2021
Q3
$209K Buy
+2,726
New +$219K ﹤0.01% 1513
2021
Q1
Sell
-12,118
Closed -$790K 1514
2020
Q4
$790K Buy
+12,118
New +$697K 0.01% 788
2020
Q3
Sell
-6,110
Closed -$292K 1307
2020
Q2
$292K Buy
+6,110
New +$295K ﹤0.01% 1030

Other funds holding GMED

AE Wealth Management's GMED Position: Q2 2025 in Review

AE Wealth Management sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 2,892 shares — an estimated $212K sold.

AE Wealth Management first reported a position in GMED in Q2 2020 and held it in 5 quarters. The position peaked at $790K in Q4 2020. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • AE Wealth Management reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • AE Wealth Management sold 2,892 Globus Medical shares in Q2 2025, an estimated $212K.
  • AE Wealth Management first reported a position in Globus Medical in Q2 2020 and held it in 5 quarters.
  • AE Wealth Management's Globus Medical position peaked at $790K in Q4 2020.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on AE Wealth Management's 13F filing for Q2 2025, filed 6 Aug 2025.